KDventures AB (LTS:0P3C) EBIT: kr-19.94 Mil (TTM As of Mar. 2026)


LTS:0P3C KDventures AB LTS:0P3C
42 GF Score
Price kr0.27
GF Value kr0.77
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is KDventures AB EBIT?

KDventures AB LTS:0P3C 42 EBIT is kr-19.94 Mil as of Mar. 2026. GuruFocus rates LTS:0P3C with a GF Score™ of 42/100 and a GF Value™ of kr0.77 (Possible Value Trap). The stock has 3 warning signs investors should review.

KDventures AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was kr-5.44 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-19.94 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. KDventures AB's annualized ROC % for the quarter that ended in Mar. 2026 was -2.15%. KDventures AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -2,096.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. KDventures AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -33.59%.


KDventures AB  (LTS:0P3C) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

KDventures AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-21.772 * ( 1 - 0% )/( (1016.945 + 1006.144)/ 2 )
=-21.772/1011.5445
=-2.15 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1111.346 - 0.521 - ( 106.313 - max(0, 6.549 - 111.23+106.313))
=1006.144

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

KDventures AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-21.772/( ( (1.163 + max(-3.887, 0)) + (0.914 + max(-5.69, 0)) )/ 2 )
=-21.772/( ( 1.163 + 0.914 )/ 2 )
=-21.772/1.0385
=-2,096.49 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 3.34) - (4.076 + 0 + 3.151)
=-3.887

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.521 + 0 + 5.169)
=-5.69

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

KDventures AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-19.943/59.367
=-33.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KDventures AB EBIT Related Terms


KDventures AB EBIT Historical Data

* Premium members only.

The historical data trend for KDventures AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KDventures AB EBIT Chart

KDventures AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 177.10 -87.28 5.39 -8.00 -193.79

KDventures AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.38 -6.13 -3.76 -4.61 -5.44

LTS:0P3C vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, KDventures AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KDventures AB EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, KDventures AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where KDventures AB's EV-to-EBIT falls into.


LTS:0P3C
42GF Score
KDventures AB LTS:0P3C
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KDventures AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-19.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-19.94 Mil mean?
KDventures AB (LTS:0P3C) has a EBIT of kr-19.94 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on KDventures AB.
Is KDventures AB's EBIT too high?
KDventures AB's current EBIT is kr-19.94 Mil. Overall, KDventures AB has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's EBIT compare to VRTX and REGN?
KDventures AB's EBIT of kr-19.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on KDventures AB. KDventures AB's current EBIT is kr-19.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
Based on GuruFocus' analysis, KDventures AB (LTS:0P3C) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.77, compared to a current price of kr0.27 — trading 65.3% below its estimated fair value. The current EBIT is kr-19.94 Mil. KDventures AB's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For KDventures AB (LTS:0P3C), the current EBIT is kr-19.94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KDventures AB (LTS:0P3C) Overvalued in 2026?

Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued. The current stock price of kr0.27 is trading 65.3% below its estimated GF Value™ of kr0.77. GuruFocus considers KDventures AB to be Possible Value Trap.

Key valuation signals for LTS:0P3C:

  • EBIT: kr-19.94 Mil
  • GF Value™: kr0.77 vs. price of kr0.27 (65.3% below fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the LTS:0P3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KDventures AB Business Description

Other Exchanges KDV:Sweden2I9:Germany
Address Nanna Svartz vag 6A, Solna, SWE, 171 65
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
42GF Score

Get the complete analysis for LTS:0P3C

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.27
Price
kr0.77
GF Value